Interview

From Lab Rats And Eyeballs To Cannabis: Scarlet Express CEO Discusses Closed-Loop Delivery, How To 'Survive In Chaos'
EXCLUSIVE: Can Data Fix Cannabis Banking? Green Check CEO Breaks Down The Solution (CORRECTED)
Lionel Messi's Hometown: Meet The Cannabis Cultivators, Breeders & Caregivers Scoring Goals For The Community
EXCLUSIVE: Can Data Fix Cannabis Banking? Green Check CEO Breaks Down The Solution (CORRECTED)
Lionel Messi's Hometown: Meet The Cannabis Cultivators, Breeders & Caregivers Scoring Goals For The Community
Holding Onto Outdated Growing Methods? Commercial Growers Explains What It Takes To Outpace The Market
Glencore, Other Experts Say US Permitting System Holding Back Domestic Battery Metals Industry

Interview Recent News

900 Pre-Rolls Per Hour? Upgrade From Manual To Automatic Speeds Up Joint Production, Enhances Margins
As pre-rolls continue to dominate the cannabis market, companies are searching for strategies to enhance margins in an increasingly competitive landscape. RollPros' latest upgrade to the Bla
EXCLUSIVE: Chariot Corp. Leads US Lithium Land Acquisition To Strengthen Domestic Supply — 'Grab As Much As You Can'
Chariot Corp. aims to acquire extensive land in the US for lithium development. Its 3,634 claims in 3 states give it a competitive advantage.
Is Old School Better? How Nostalgia Cannabis' Vintage Strains Are Reshaping Cannabis Markets
This article is part of Benzinga Cannabis' series ‘Cultivator Chronicles,' which focuses on the latest trends, developments and major players in the cannabis cultivation.
'There Are Now Over 234 Leveraged And Inverse ETFs': Leveraged ETFs Surge In Popularity Among Traders, Says Expert
Eliott Wellenbach and Gianni Di Poce discuss ETFs during Benzinga's 'Level Up Your Trading with Leveraged ETFs' virtual event.
How Strategic Real Estate Investments Are Driving Psychedelic Therapy's Growth, Bridging Gaps In Mental Healthcare
Explore how Healing Realty Trust is transforming psychedelic therapy through strategic real estate investments, paving the way for growth.
$2.9B European Cannabis Market: A Strategic Blueprint For Cross-Border Transportation Logistics
Tapping Expert Insights On EU Cannabis Logistics
Maintaining A Balanced Accounts Receivable Sheet In Cannabis: CEO Of Gold Flora Shares Her Secret
Not DC, But The States: Tim Seymour Discusses How Red States Could Catalyze Cannabis Growth
Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is a key voice in the cannabis investment community.
EXCLUSIVE: Meta's AI, Metaverse Growth Drive Launch Of New Direxion Leveraged And Inverse ETFs
New ETFs from Direxion, METU and METD, provide traders with tools to capitalize on short-term movements of Meta Platforms Inc (NASDAQ:META) stock.
EXCLUSIVE: Josh Kesselman On Building RAW Rolling Papers - 'There's Always Another Level'
Explore Josh Kesselman's journey with RAW Rolling Papers, his dedication to social impact, and integration into cannabis culture. Read now!
Tim Seymour On Running A Cannabis Fund: 'We Focus On Companies Poised For Growth'
Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is renowned for recognizing the potential of the cannabis sector early on.
EXCLUSIVE: Femasys At Inflection Point And Undervalued, Expects Growth Potential Following Roe v. Wade Overturn, CEO Says
Femasys focuses on innovative women's healthcare solutions. Their FemBloc product, a non-surgical permanent birth control, is in late-stage development, aiming for a $20 billion market.
EXCLUSIVE: 'Prescription Erectile Dysfunction Market Could Triple If an ED Therapy Is Made Available OTC,' Petros Pharma President Says
Petros Pharmaceuticals specializes in men's health therapeutics. President Fady Boctor discusses the company's strategy to make key prescription medications. Petros is poised to expand within the $66.5 billion Rx-to-OTC market projected by 2033.

Explore Benzinga's Financial Tools

Find Stocks Tailored to Your Trading Interests
Find Stocks Tailored to Your Trading Interests
Benzinga Pro offers a real-time newsfeed as headlines break on earnings releases, analyst ratings, rumors, the biggest movers, and many more actionable alerts.

Compare Benzinga's Favorite Brokers

Claim Exclusive Offers

Claim Exclusive Offers

Compare Benzinga's Favorite Cryptocurrency Brokers

Claim Exclusive Offers